|
|
|
Corporate Profile: Acadia
Pharmaceuticals
| Summary: |
| Acadia
is an emerging leader in the application of chemical-genomics
to drug discovery. Their uniquely productive platform
integrates genomics, chemistry and biology to identify
and validate drug targets and discover novel chemistries
specific to those targets. They have successfully
applied our chemical-genomics platform to generate
a broad drug discovery pipeline consisting of 16
programs that address large unmet medical needs.
They have advanced three of these programs to development
in the areas of psychosis, chronic pain and glaucoma,
and several other programs are in late-stage preclinical
testing. |
| Address (HQ): |
11085 Torreyana Road
Suite 100
San Diego, CA 92121-1104 |
| Phone #'s (HQ): |
| Main |
(858) 558-2871 |
| Human
Resources |
not known |
| Investor
Relations |
(858) 558-2871 |
| Fax #'s (HQ): |
| Main |
(858) 558-2872 |
| Human
Resources |
(858) 450-5008 |
| Investor
Relations |
(858) 558-2871 |
| Financial
information: |
| ACAD |
| Issued United States patents: |
| Issued U.S.
patents 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
